Social distancing proves tough for burns treater AVITA

This post was originally published on this site

The boss of spray-on-skin burns treatment biotech Avita Therapeutics has said the company faced one of the toughest quarters since launching its technology in the US market due to challenges resulting from coronavirus stay-at-home orders. “We are …

Click here to read full article